Planning future strategies for domestic and international neuroAIDS research, july 24-25, 2008

Journal of Neuroimmune Pharmacology

Volumn 4, Issue 3, 2009, Pages 283-297

  Joseph, Jeymohan ^a   Clifford, David ^b   Douglas, Steven D ^c   Fox, Howard ^d   Gendelman, Howard E ^d   Gonzalez Scarano, Francisco ^c   Grant, Igor ^e   Major, Eugene ^f   McArthur, Justin ^g  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiretroviral therapy; Drug abuse; HIV neuropathogenesis; NeuroAIDS; Neuroinflammation

Indexed keywords

A 3 G; ANTIVIRUS AGENT; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CEP 1347; MARAVIROC; MITOGUAZONE; RN 18; RN 19; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL THERAPY; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; DEMENTIA; FINANCIAL MANAGEMENT; GENETIC EPIDEMIOLOGY; HIV ASSOCIATED DEMENTIA; INTERNATIONAL COOPERATION; MEDICAL RESEARCH; NANOTECHNOLOGY; NATIONAL HEALTH ORGANIZATION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RESEARCH PRIORITY; VIRAL GENETICS; VIRUS CELL INTERACTION; VIRUS ENCEPHALITIS; VIRUS TRANSMISSION;

AIDS DEMENTIA COMPLEX; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COMPLEMENT SYSTEM PROTEINS; HIV INFECTIONS; HIV-1; HUMANS; NERVE DEGENERATION; RESEARCH; RESEARCH SUPPORT AS TOPIC;

EID: 68749116305     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-009-9159-1     Document Type: Article

References (0)